Zenith Capital Corp.
OTC: ZHCLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Donald J. McCaffrey
- Employees
- 50,477
- Headquarters
- Calgary, Canada
- IPO year
- 2021
- Market cap
- $1.8M
- Website
- https://www.zenithepigenetics.com
Loading ZHCLF…
Loading profile data…Frequently asked questions about ZHCLF
What does Zenith Capital Corp. (ZHCLF) do?
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration wit...
Where does ZHCLF trade?
Zenith Capital Corp. (ZHCLF) trades on the Other OTC.
What sector is ZHCLF in?
Zenith Capital Corp. (ZHCLF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zenith Capital Corp.?
Donald J. McCaffrey is the chief executive officer of Zenith Capital Corp. (ZHCLF).
Where is Zenith Capital Corp. headquartered?
Zenith Capital Corp. is headquartered in Canada.
Does ZHCLF pay a dividend?
Zenith Capital Corp. (ZHCLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZHCLF go public?
Zenith Capital Corp. (ZHCLF) completed its initial public offering in 2021.